The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials

Author： Deerhake Jacob   Merz Julie   Cooper Jeanna   Eagle Kim   Fay William  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.23, Iss.2, 2007-04, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardization of QRS Duration Measurement and LBBB Criteria in CRT Trials and Clinical Practice

By  

Current Cardiology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 20-23

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Dehydroepiandrosterone Therapy in Clinical Practice

By Cameron Deborah R.   Braunstein Glenn D.  

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 95-114

Adis International

Access to resources Recommend Favorite

Update on Clinical Trials of Antiplatelet Therapy for Cerebrovascular Diseases

By  

Cerebrovascular Diseases, Vol. 10, Iss. 5, 2004-11 ,pp. : 34-40

Karger

Access to resources Recommend Favorite

Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta‐analysis of 16 Clinical Trials and 9185 Patients

By  

Clinical Cardiology, Vol. 38, Iss. 8, 2015-08 ,pp. : 499-509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice

By  

Digestive Diseases, Vol. 33, Iss. 5, 2015-09 ,pp. : 668-674

Karger

Access to resources Recommend Favorite